FDA Shortage Status Determinations: The FDA has issued determinations that the tirzepatide injection product shortage is resolved (decision memorandum dated December 19, 2024) and that the semaglutide injection product shortage is resolved (decision memorandum dated February 21, 2025)
When I asked about potential side effects and requested a conversation before starting the medication, I was simply advised to read about the symptoms first and decide for myself
We have solutions for mass cell disorders, for gut dysbiosis, for gut healing, food sensitivities, for Epstein Barr, and anything you can imagine, even overall just immune function
"An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist." Journal of Sexual Medicine 2006;3(4):628-638